This topic contains a solution. Click here to go to the answer

Author Question: A researcher wants to know whether a new drug reduces anxiety. Forty participants who suffer from ... (Read 88 times)

eruditmonkey@yahoo.com

  • Hero Member
  • *****
  • Posts: 546
A researcher wants to know whether a new drug reduces anxiety. Forty participants who suffer from anxiety disorder are assigned randomly to one of two groups. One group gets the new drug and the other group gets a placebo. Neither group knows which they receive. After 30 days on the drug, their anxiety levels are measured. In this experiment, is the independent variable and is the dependent variable.
 
  a. anxiety, the new drug
  b. the new drug, the placebo
  c. anxiety, the placebo
  d. the new drug, anxiety

Question 2

Identify the three types of nonequivalent control group designs discussed in the text noting possible advantages or disadvantages of each.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Athena23

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

D

Answer to Question 2

Posttest-only designs have no equivalent control group for comparison, and there are no pretest measures to establish the equivalency of groups. Pretest/posttest designs allow us to compare the groups on the pretest and posttest, and to compare within groups from pretest to posttest. However, because participants are not randomly assigned, we cannot say they are equivalent. Time-series designs allow us to see the effect of the treatment over time because many measures are taken. There is a nonequivalent control group available for comparison; however, because participants are not randomly assigned, we cannot say they are equivalent.




eruditmonkey@yahoo.com

  • Member
  • Posts: 546
Reply 2 on: Jun 19, 2018
Excellent


phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library